ArticleThe Journal of international medical research2026
Association of red cell distribution width-to-albumin ratio with mortality in adults with low muscle mass: A retrospective cohort study.
Article in The Journal of international medical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BackgroundThe red cell distribution width-to-albumin ratio (RAR) is a novel composite biomarker that reflects both inflammatory and nutritional status. Although the RAR has been associated with various chronic disease outcomes, its relationship with mortality risk in adults with reduced muscle mass has not been systematically evaluated.MethodsWe analyzed data from 1494 adults with reduced muscle mass enrolled in 6 cycles of the US National Health and Nutrition Examination Survey (2003-2006 and 2011-2018). Kaplan-Meier survival analysis, Cox proportional hazards regression, restricted cubic spline models, and time-dependent receiver operating characteristic curves were used to comprehensively assess the association between RAR and mortality risk. Subgroup and interaction analyses were conducted to evaluate the robustness of the findings.ResultsDuring a median follow-up of 104 months, a higher RAR was linearly associated with increased risks of all-cause and cardiovascular mortality. Compared with Q1, Q4 was associated with a 154% and 216% higher risk of all-cause and cardiovascular mortality, respectively. These associations were generally consistent across subgroups, with a significant interaction by sex indicating stronger associations among men. Time-dependent area under the curve analyses demonstrated that the RAR outperformed the neutrophil-to-lymphocyte ratio, systemic immune-inflammation index, and neutrophil-to-albumin ratio at most time points, with the exception that the neutrophil-to-lymphocyte ratio slightly exceeded RAR for 5-year cardiovascular mortality.ConclusionRAR is positively associated with mortality risk in adults with reduced muscle mass. RAR may serve as a practical biomarker for risk stratification in this population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.